Healthcare provider profile · identity verified

Philip A Moore, M.D.

Internal Medicine · AURORA, IL · NPI 1104877414

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	479	133
Levothyroxine Sodium	Levothyroxine Sodium	392	107
Amlodipine Besylate	Amlodipine Besylate	281	102
Pantoprazole Sodium	Pantoprazole Sodium	220	84
Omeprazole	Omeprazole	207	59
Metoprolol Succinate	Metoprolol Succinate	202	81
Gabapentin	Gabapentin	195	52
Lisinopril	Lisinopril	173	59
Tamsulosin Hcl	Tamsulosin Hcl	160	55
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	152	50
Metformin Hcl	Metformin Hcl	149	54
Losartan Potassium	Losartan Potassium	146	42
Potassium Chloride	Potassium Chloride	141	33
Furosemide	Furosemide	129	44
Metoprolol Tartrate	Metoprolol Tartrate	128	43
Escitalopram Oxalate	Escitalopram Oxalate	124	36
Memantine Hcl	Memantine Hcl	117	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	38
Simvastatin	Simvastatin	111	40
Trazodone Hcl	Trazodone Hcl	110	27
Carvedilol	Carvedilol	108	32
Clopidogrel	Clopidogrel Bisulfate	105	30
Eliquis	Apixaban	104	26
Alprazolam	Alprazolam	103	25
Tramadol Hcl	Tramadol Hcl	99	36
Mirtazapine	Mirtazapine	95	26
Cefuroxime	Cefuroxime Axetil	93	73
Sertraline Hcl	Sertraline Hcl	93	23
Methylprednisolone	Methylprednisolone	88	66
Cephalexin	Cephalexin	85	62
Celecoxib	Celecoxib	78	31
Donepezil Hcl	Donepezil Hcl	78	16
Famotidine	Famotidine	78	24
Meloxicam	Meloxicam	75	32
Hydralazine Hcl	Hydralazine Hcl	70	23
Spironolactone	Spironolactone	68	21
Fluticasone Propionate	Fluticasone Propionate	67	24
Bumetanide	Bumetanide	66	24
Alendronate Sodium	Alendronate Sodium	64	suppressed
Allopurinol	Allopurinol	62	21
Montelukast Sodium	Montelukast Sodium	62	20
Prednisone	Prednisone	61	31
Finasteride	Finasteride	60	22
Warfarin Sodium	Warfarin Sodium	56	14
Fluoxetine Hcl	Fluoxetine Hcl	55	14
Duloxetine Hcl	Duloxetine Hcl	54	17
Rosuvastatin Calcium	Rosuvastatin Calcium	54	18
Glimepiride	Glimepiride	53	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	27
Albuterol Sulfate Hfa	Albuterol Sulfate	49	27
Synthroid	Levothyroxine Sodium	46	12
Atenolol	Atenolol	45	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	32
Azithromycin	Azithromycin	41	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	36	suppressed
Irbesartan	Irbesartan	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	26
Lorazepam	Lorazepam	33	13
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Xarelto	Rivaroxaban	32	13
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	24
Ezetimibe	Ezetimibe	30	12
Sucralfate	Sucralfate	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Topiramate	Topiramate	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	suppressed
Latanoprost	Latanoprost	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	21
Hydrochlorothiazide	Hydrochlorothiazide	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Metolazone	Metolazone	25	suppressed
Nystatin	Nystatin	24	16
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Digoxin	Digoxin	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Fentanyl	Fentanyl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Calcitriol	Calcitriol	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	18	suppressed
Fluconazole	Fluconazole	18	14
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Glipizide	Glipizide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Diazepam	Diazepam	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	11
Mometasone Furoate	Mometasone Furoate	13	suppressed
Torsemide	Torsemide	13	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error